SCARB1 and B-cell non-Hodgkin lymphoma: We have demonstrated that certain B cell lymphomas highly express SCARB1, and targeted treatment with the HDL NPs potently induces in vitro and in vivo cell death by inhibiting cholesterol ester uptake and reducing cell cholesterol (23, 26, 27).